Literature DB >> 7734426

Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance.

J Alferink1, B Schittek, G Schönrich, G J Hämmerling, B Arnold.   

Abstract

To follow the fate of tolerant T cells in vivo we used a transgenic mouse model in which peripheral T cell tolerance was based on a non-deletional mechanism. These mice expressed two transgenes: the MHC class I molecule Kb under the keratin IV promoter on keratinocytes (2.4 KerIV-Kb) and an anti-Kb TCR identified by the anti-clonotypic antibody Désiré-1 (DES-TCR). Although these mice were tolerant to Kb skin grafts, CD8+DES+ T cells were present in their lymphoid organs in the same numbers as in Kb-reactive DES-TCR single-transgenic mice. The unresponsiveness towards Kb grafts suggested previous contact of the CD8+DES+ T cells with the Kb molecule on keratinocytes, but the evidence was indirect. The present study demonstrates enhanced levels of activation markers like CD44 and CD2 on the tolerant T cells, indicating contact with the Kb molecule. Continuous presence of antigen was required for maintenance of the tolerant state as shown by transfer of tolerant T cells into Kb-negative nu/nu BALB/c mice. Three days after cell transfer most recipients were still tolerant and accepted Kb-positive skin grafts, but 2 weeks after transfer the transferred cells had recovered their responsiveness and rejected Kb grafts. In order to see if contact with the tolerogen would eventually drive the tolerant cells into cell death, the life span of tolerant CD8+DES+ cells was measured in thymectomized DES-TCR x 2.4 KerIV-Kb double-transgenic mice. The tolerant cells were found to have a life span of at least 8 weeks, which was comparable with the life span of non-tolerant CD8+DES+ cells from DES-TCR single-transgenic mice. Thus, tolerant T cell populations can be long-lived and need continuous contact with the tolerogen to remain tolerant.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7734426     DOI: 10.1093/intimm/7.2.331

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The contributions of T-cell anergy to peripheral T-cell tolerance.

Authors:  R Lechler; J G Chai; F Marelli-Berg; G Lombardi
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 3.  Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?

Authors:  M Peakman; C M Dayan
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

4.  In vivo maintenance of T-lymphocyte unresponsiveness induced by thymic medullary epithelium requires antigen presentation by radioresistant cells.

Authors:  Denis Hudrisier; Sonia Feau; Véronique Bonnet; Paola Romagnoli; Joost P M Van Meerwijk
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

5.  CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen.

Authors:  Roland Reibke; Natalio Garbi; Ruth Ganss; Günter J Hämmerling; Bernd Arnold; Thilo Oelert
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-28       Impact factor: 11.205

6.  Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions.

Authors:  B Metzler; D C Wraith
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

7.  Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells.

Authors:  Jason R Lees; Bridget Charbonneau; Axel K Swanson; Robert Jensen; Jianfeng Zhang; Robert Matusik; Timothy L Ratliff
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

8.  Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology.

Authors:  S Ehl; J Hombach; P Aichele; T Rülicke; B Odermatt; H Hengartner; R Zinkernagel; H Pircher
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.